Hepatitis B: all 1,662 studies
Page 15 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BStatus unknownNCT00921180Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis BStatus unknownNCT00917761Phase 4
- Validity and Cost-Effectiveness of a New Screening Test for Hepatocellular CarcinomaCompletedNCT00912847
- Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedNCT00907894Phase 1
- Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver TransplantationCompletedNCT00895713Phase 2
- Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BCompletedNCT00895596Phase 1/2
- Community-based Hepatitis B Interventions for Hmong AdultsCompletedNCT00888407Not applicable
- Hepatitis B Vaccination (HBV) in HIV Infected ChildrenCompletedNCT00886964Phase 2
- PEG-IFN in HBV Patients With Incomplete Response to NACompletedNCT00883844Phase 4
- Activation of Hepatitis B Virus (HBV) in Hepatitis B Surface Antigen (HBsAg) - Negative But Hepatitis B Core Antibody (Anti-HBc) - Positive PatientsCompletedNCT00881036
- Immunogenicity and Safety of Primary and Booster Vaccination With DTPa-HBV-IPV/Hib VaccineCompletedNCT00880477Phase 3
- Immunogenicity and Reactogenicity of GSK Bio DTPa-HBV-IPV and Hib Vaccines When Coadministered to Healthy InfantsCompletedNCT00879827Phase 3
- Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis BCompletedNCT00877760Phase 4
- Safety, Long Term Immunogenicity and Lot Consistency Study of Liquid Pentavalent Combination VaccineStatus unknownNCT00877357Phase 4
- Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis BCompletedNCT00877149Phase 4
- Risk of Hepatitis B Virus Reactivation in Patients Undergoing AllograftingCompletedNCT00876148
- Observational Study of Immune Response to Hepatitis B Childhood BoosterCompletedNCT00873652
- Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 WeeksWithdrawnNCT00862706Phase 4
- Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis BStatus unknownNCT00860626Not applicable
- A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis BCompletedNCT00857675Phase 3
- Antigen-specific Immune Response to Hepatitis B Virus in UteroStatus unknownNCT00845403
- An Hepatitis B Vaccine Model for HIV Vaccine Trials in Drug UsersCompletedNCT00841477Phase 3
- Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver TransplantationCompletedNCT00838071Phase 3
- Efficacy of Sequential TACE and PVE on the Resectability of Hepatitis B Related HCCCompletedNCT00834158Not applicable
- Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver CancerCompletedNCT00824707Not applicable
- Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease PatientsStatus unknownNCT00823550Phase 4
- ANRS HB 05 Multicenter Study Evaluating Efficacy and Safety of Clevudine Monotherapy Versus Tenofovir Monotherapy Versus Combination Therapy of Clevudine and Tenofovir for 96 Weeks in HBeAg Negative Patients With Chronic Hepatitis B, naïve to Anti-VHB TherapyTerminatedNCT00823342Phase 3
- Sonazoid Enhanced Liver Cancer Trial for Early DetectionStatus unknownNCT00822991Not applicable
- A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BStatus unknownNCT00815464Not applicable
- Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionStatus unknownNCT00810524Phase 4
- Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)CompletedNCT00804622Phase 2
- Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver TransplantationWithdrawnNCT00800787Phase 3
- Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B PatientsTerminatedNCT00798460Phase 4
- Maraviroc Versus Etravirine In Combination With Antiretroviral Therapy In Drug Experienced HIV And Hepatitis Co-Infected PatientsWithdrawnNCT00782301Phase 4
- Hepatitis B and HIV Co-Infection in Patients in UgandaCompletedNCT00782158
- Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis BCompletedNCT00781105Phase 4
- Prednisolone Priming Study in Patients With Chronic Hepatitis BStatus unknownNCT00778596Phase 4
- Evaluation the Possible Influence of Transcatheter Arterial Chemoembolization on Hepatitis B Viral ReplicationCompletedNCT00769730
- Efficacy of Antiviral Therapy After Radical Resection for Hepatitis B Virus-Related Hepatocellular CarcinomaStatus unknownNCT00768157Phase 4
- Genetic Analysis of Liver CancerTerminatedNCT00768001
- Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular CarcinomaTerminatedNCT00767936
- Increasing Hepatitis B Screening Among Korean Church AttendeesCompletedNCT00760721Phase 3
- Randomized Placebo-controlled Trial Evaluating the Safety and Efficacy of Silymarin Treatment in Patients With Acute Viral HepatitisTerminatedNCT00755950Phase 2/3
- A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis BStatus unknownNCT00753467Phase 2
- Hepatitis B Acceptability and Vaccination Incentive TrialCompletedNCT00744289Not applicable
- Response to Hepatitis B Vaccine in Celiac Disease PatientsTerminatedNCT00739128Not applicable
- Evaluation of HepaGam B® in Combination With Antiviral Treatment in Hepatitis B Liver Transplant PatientsCompletedNCT00722332Phase 4
- The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular CarcinomaStatus unknownNCT00720668
- Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B PatientsWithdrawnNCT00715715Not applicable
- Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis BCompletedNCT00713986Phase 3
- Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis BWithdrawnNCT00710216Phase 4
- Hepatitis B Virus (HBV) Viral Suppression by Entecavir in Adefovir Partial RespondersCompletedNCT00704106
- Seroprevalence of Hepatitis B Infection and Effect of Booster Response Amongst Taiwanese Young AdultsStatus unknownNCT00702663
- Evaluation of Immunogenicity, Reactogenicity and Safety of HBV-MPL Vaccine vs Engerix™-B, in Haemodialysis PatientsCompletedNCT00699231Phase 1
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 19-40 yCompletedNCT00698906Phase 2
- Comparing Immunogenicity and Safety of Different Formulations of HBV-MPL Vaccine With Engerix™-B in Adults Aged 18-40 yCompletedNCT00698555Phase 2
- Comparison of Safety, Immuno- and Reactogenicity of MPL-Adjuvanted Recombinant Hepatitis B Vaccine to That of Engerix™-BCompletedNCT00698087Phase 3
- Immunogenicity and Safety of an Adjuvanted HBV Vaccine Compared to Engerix™-B, in a Non-responder Population ≥ 15yCompletedNCT00698061Phase 3
- Evaluation of Immunogenicity and Reactogenicity of Various Formulations of Recombinant Hepatitis B VaccineCompletedNCT00697970Phase 3
- Immunogenicity and Reactogenicity of MPL Adjuvanted Recombinant Hepatitis B- Vaccine and Engerix™-B in Adult Non-RespondersCompletedNCT00697931Phase 3
- Consistency of 3 Consecutive Lots of a Novel HBV Vaccine With Single-blind Safety Evaluation Using Engerix™-B as ControlCompletedNCT00697866Phase 3
- Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy AdultsCompletedNCT00697853Phase 2
- Safety, Immunogenicity and Reactogenicity of Recombinant Hepatitis B Vaccine (Adjuvanted & New Formulation) and Engerix™-BCompletedNCT00697840Phase 3
- Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy AdolescentsCompletedNCT00697775Phase 2
- Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Healthy Volunteers Positive for the HLA-DQ2 GenotypeCompletedNCT00697749Phase 3
- Immunogenicity and Safety of a Novel Adjuvanted HBV Vaccine in Pre-liver Transplant Patients 18 Years of AgeCompletedNCT00697554Phase 3
- Comparison of Immuno, Reacto and Safety of Recombinant Hepatitis B Vaccine With or Without MPL in Healthy Older AdultsCompletedNCT00697242Phase 3
- Immunogenicity & Reactogenicity of HBV-MPL Vaccine and Engerix™-B in Healthy Adults Following 2 Different SchedulesCompletedNCT00697229Phase 2
- Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Adults (15-40 Yrs).CompletedNCT00697216Phase 3
- Immunogenicity & Reactogenicity of Various Formulations of Recombinant Hepatitis B Vaccine With Different AdjuvantsCompletedNCT00697125Phase 2
- Safety and Immunogenicity of 3 Lots of GSK Biologicals' HBV-MPL Vaccine and Engerix™-B in Healthy Volunteers ≥ 15yCompletedNCT00696917Phase 3
- Study Comparing Immunogenicity, Reactogenicity and Safety of GSK Bios' HBV-MPL Vaccine With That of Engerix™-B in AdultsCompletedNCT00696891Phase 3
- A Study to Assess the Anamnestic Immune Response in Healthy 4 to 7 Year-old Children After a Primary Vaccination Series With Either HEXAVAC® or INFANRIX®-HEXACompletedNCT00693186Phase 3
- Phase IV Interchangeability Study of a Liquid Pentavalent Combination VaccineCompletedNCT00674908Phase 4
- Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)CompletedNCT00670839Phase 3
- Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related CirrhosisStatus unknownNCT00663182Phase 4
- Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)Status unknownNCT00662194
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedNCT00661076Phase 3
- A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected PatientsStatus unknownNCT00660361
- A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)CompletedNCT00651209Phase 4
- Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis BCompletedNCT00646503Phase 4
- CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation StudyCompletedNCT00645736
- Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBVCompletedNCT00645294Phase 1/2
- PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsCompletedNCT00644761Phase 2
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedNCT00641082Phase 4
- Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedNCT00640588Phase 3
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNACompletedNCT00637663Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Genetic Polymorphisms of Interleukin-1B and TNF-A and HBV-Related Hepatocellular CarcinomaCompletedNCT00629486Not applicable
- Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNACompletedNCT00625560Phase 4
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNACompletedNCT00625339Phase 4
- Safety and Immunogenicity Study of a Liquid Pentavalent Combination VaccineCompletedNCT00617812Phase 4
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.CompletedNCT00614471Phase 4
- Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnNCT00606099Phase 4
- Study to Show That the Combined Hepatitis A and B Vaccine is Non-inferior to Monovalent Vaccines in AdultsCompletedNCT00603252Phase 4
- Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis BStatus unknownNCT00597259Phase 4
- A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated CirrhosisCompletedNCT00562783Phase 2
- Long-term Study With ClevudineCompletedNCT00558818Phase 4
- Switching Study From Lamivudine to Clevudine in the Chronic Hepatitis B PatientsCompletedNCT00558493Phase 4
- To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB)CompletedNCT00537537Phase 4